BioCurex

Contact
biocurex.com
+16042079150

BioCurex, Inc.

Suite 215, 7080 River Road
V6X 1X5 Richmond, BC
Canada

Phone

biocurex.com
Contact
Profile Products News
Contact

About BioCurex

BioCurex Inc. is a biotechnology company that is developing products based on patented/proprietary technology for cancer diagnosis and therapy. The core technology identifies a cancer marker known as RECAF, found only on malignant cells in a variety of cancers, but absent in normal and most benign cells. Biocurex is also working on further methods for cancer detection and cancer treatment.

Read more about BioCurex
Facts about BioCurex
  • Industry : Pharma

Product portfolio of BioCurex

Product portfolio

Show all

News about BioCurex

BioCurex

08-Nov-2010 | research and development

BioCurex Announces Filing of New Patent For Cancer Diagnostics, Therapeutics Based on its Proprietary RECAF Technology

BioCurex Inc. announced that it has filed a new patent within the Patent Cooperation Treaty, which presently includes 142 countries. The subject of this ...

Read news
BioCurex

09-Jul-2010 | research and development

BioCurex Announces Positive First Results for Monitoring Cancer Therapy Using its RECAF Blood Test

BioCurex Inc. announced its first set of results supporting the use of the BioCurex RECAF blood test to monitor cancer therapy. The test included samples ...

Read news
BioCurex

10-Nov-2008 | business & finance

BioCurex Incorporates Chinese Subsidiary

BioCurex Inc. as incorporated a fully-owned subsidiary, BioCurex China, in Shanghai. This followed a lengthy legal process - required of all foreign ...

Read news
BioCurex

19-Sep-2008 | research and development

BioCurex Obtains First Patent on Therapeutic Applications for Proprietary RECAF marker

BioCurex Inc. announced that the Australian Patent Office has issued a notice of acceptance for a divisional application of our original patent filing. ...

Read news
BioCurex

31-Jul-2008 | research and development

BioCurex Files New RECAF Patent

BioCurex Inc. announced that it has filed a new patent application to protect certain methods of purifying and detecting RECAF in bodily fluids. The patent ...

Read news
BioCurex

28-Mar-2008 | research and development

European Patent Office Grants Patent for BioCurex's RECAF Blood Tests

BioCurex Inc. announced that the European Patent Office (EPO) has granted the Company's patent claims for cancer diagnostic serum tests based on the RECAF ...

Read news
BioCurex

11-Jan-2008 | business & finance

BioCurex Licenses RECAF Technology to Inverness Medical Innovations

BioCurex and Inverness Medical Innovations have announced a licensing agreement for BioCurex's RECAF material and technology. RECAF (the receptor for alpha ...

Read news
BioCurex

27-Sep-2007 | science

Dr. Stewart Sell Wins ISOBM-Abbott Award

Dr. Stewart Sell, a member of BioCurex's Scientific Advisory Board, has been awarded the prestigious ISOBM-Abbott award for his lifetime achievements in ...

Read news
Show more news about BioCurex

Here you will find BioCurex, Inc.

Last viewed contents

Category:Antiasthmatic_drugs

Go to page

Evotec and Indivumed announce drug discovery collaboration on precision medicine for colorectal cancer

Go to page